Catalyst Wire Dossier Catalyst Wire Dossier

Adenovirus-based malaria vaccine

Adenovirus vector-based malaria vaccine · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adenovirus-based malaria vaccine, covering 2014-09-22 to 2014-09-22. Get the full timeline:

Most recent: Clinical Trial Update: Adenovirus Vaccine for Malaria [Phase 1]

See pricing